Investment News Show Replays
Best Small Cap Stocks To Buy Investing Show
Money Info Airs
10 AM to 11 AM EDT
Every Tuesday
LISTEN LIVE
Use this Link To Watch The Show:
www.princetonresearch.com/money-info-live.htm
Be On The Air With Us
Call In Your Questions
888-792-1590
Money Info
The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.
The show is broadcast live on the internet and on the air from the studios of Radio Station WPSL AM 1590, Port St. Lucie, Florida — The Talk of the Treasure Coast
Money Info is hosted by investing experts Mike King and Charles Moskowitz together with radio broadcasting professional Greg Wyatt.
Watch Money Info
Investment News Show Replays
September 29, 2015 Show:
The September 29 show features a live with
Jack Gregory, founder of
Premier Holding Corporation
(Stock Symbol: PRHL)
Listen To Show Replay Part 1:
Listen To Show Replay Part 2 with Jack Gregory, founder of Premier Holding Corporation interview:
Hear a replay of Part 2 of the Show with Premier Holding Corporation CEO Randall Letcavage interview:
See the Premier Holding Corporate Site
Get PRHL stock quote and trading chart
Premier Holding Corporation
Mr. Letcavage has a compelling story building Premier, a vertically integrated energy company with three interactive subsidiaries strategically positioned to capitalize on energy deregulation.
The show will discuss the dynamics and benefits of Premier’s business model of the acquisition of synergistic subsidiaries that accumulate and service residential and commercial energy consumers collectively offering and delivering cost savings and state of the art energy efficient products and services.
The deregulated energy business is estimated to be a $500 billion+ industry in the U.S. (roughly 5-7 times larger than the lucrative telecom deregulation market of the early 1980’s) The U.S. Energy Information Administration indicates the deregulated retail electric supply market in the northeast alone exceeds $75 billion annually, further noting the current New York market to be approximately $7.7 billion.
PRHL – PREMIER HOLDING CORPORATION
Premier Holding Corporation is a publicly traded energy services holding company. In addition to the energy and business management expertise of its subsidiaries, the Principals of PRHL possess decades of experience in mergers and acquisitions. PRHL provides much-needed strategic management, as well as financial support, which includes access to capital, financing expertise and legal structure to the deregulated power and energy efficiency markets.(PRHL.OB).
Premier Holding has already affected its business model of acquiring and integrating powerful and complementary businesses in the energy sector to provide a very broad range of products and services in the energy management field. PRHL has strategically formed a company that is “Everything Energy”. PRHL’s companies have vast experience in technologies and services for deregulated power and much- needed expertise in energy reduction.
Randall Letcavage — Chairman, CEO, President
Mr. Letcavage has recently been named Chairman, CEO, and President of Premier Holding Corp! He brings in excess of 25 years plus of business experience specializing in the financial markets and business consulting and green energy/clean technology. For the past 20 years Mr. Letcavage has been an investment banker widely recognized for individual achievements as well as his role of Founder, Officer and Director of the iCapital Group that includes iCapital Finance Inc, iCapital Advisory LLC and iCap Development LLC (A National “CDE” Community Development Entity – Certified by the U.S Treasury Department).
Mr. Letcavage has also held executive positions, invested, and/or operated numerous businesses including related companies in “Power Generation and Power Reduction” – CEO of Ciralight Global Inc, CEO of Green Central Holdings, Consultant and second largest shareholder of publicly traded PRHL which operates Energy Efficiency Experts (E3 acting President of Kratos Power. Further Mr. Letcavage is no stranger to deregulation as he has participated in over $1 Billion in Telecom financing.
Energy Stock News
Premier Holding Subsidiary Energy Efficiency Experts (E3) Becomes a Preferred Vendor to Kaiser Foundation Hospitals — E3 to Start Projects at Two California Hospitals Immediately — See News
Premier Holding Subsidiary, Energy Efficiency Experts (E3), Selected to Provide LED Lighting to Inland Star – E3 Closes Another Large LED Project for a Major Warehouse in California — See News
Premier Holding Corp. Subsidiary, The Power Company, Sets Another All-Time Sales Record In June – The Power Company (TPC) Continues to Reach New Heights With Another All-Time Record for Residential Deregulated Power Sales Solidifying it as a Market Leader — See News
September 15, 2015 Show:
Medical Stock News
Undervalued Medical Stock on Investment News Show
The September 15th show features a live interview with:
Medical Products Company,
RMS Medical Systems, Inc.
(Stock Symbol: REPR)
President and Chairman of the Board
Listen to show replay Part 1:
Listen to show replay Part 2 with Andrew Sealfon of RMS Medical Systems Interview:
RMS Medical Products is a U.S. manufacturer of medical devices which maintains offices and manufacturing facilities in Chester, NY. They employ 60 people. For more than three decades, the company has been a leading innovator in the medical device industry in the development and production of proprietary devices and supplies.
Principal products include the Freedom 60 Syringe Infusion System, RMS High-Flo Subcutaneous Safety Needle Sets and the RES-Q-VAC Medical Suctioning Pump. In addition to being regulated by the FDA which has the authority to approve medical devices for marketing in the U.S., RMS complies with ISO International standards for quality development and manufacturing. RMS Medical Products is a d/b/a of Repro-Med Systems, Inc which was founded in 1980.
Visit the corporate website: RMSMedicalProducts.com
Click Here For REPR stock quotes,
trading charts and latest news releases
The Freedom60 has a proprietary technology that
makes it desirable for the delivery of medications.
In a variety of therapies. It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “ dynamic equilibrium” which safely adjusts the flow of medication in accordance with what the patient’s body can accept.
This minimizes complications often encountered with other infusion systems which can lead to site reactions and discomfort for the patient. The portability and simple operation of the FREEDOM60.
Improves quality of life for patients who otherwise might have to use a complicated electronic pump mounted to a cumbersome infusion pole. Patients then don’t have to be confined.
RMS High-Flo Subcutaneous Safety Needle Sets are being welcomed by healthcare providers and patients alike for their consistently high quality. The infusion sets are an ideal companion for the company’s FREEDOM 60 pump, but can be used with any manufacturer’s infusion pump as well.
RES-Q-VAC is a hand-held suction pump used to clear a patient’s airway or for other purposes when reliable hospital quality suctioning is needed. It uses patented technology to protect users from airborne pathogens and spillage of suctioned material. It is used by emergency service personnel and other first responders, as well as in hospitals and other institutions. There also is a version for use by dentists. RES-Q-VAC is invaluable in the event of disasters where power is lost because it doesn’t require electricity.
The Freedom 60 Syringe Infusion System is a method for administering medication through a small needle to the subcutaneous tissue, which is the fatty tissue just under the skin. Subcutaneous infusion allows medication into the vascular system more slowly. Combined with more frequent delivery this provides more consistent and stable blood levels. The elimination of large swings in these levels decreases side effects improving overall quality of life. RMS provides High-Flo needles to optimize liquid flow. Their smaller 26 gauge high flow needle flows at the same rate as the considerably larger 24 gauge needles, which are considerably less painful when entering the skin.
STRONG GROWTH CONTINUES
REPR Annual Revenue and Profits Continue To Increase
New health insurance changes are forcing more and more home health care
A sector in which REPR excels.
Repro-Med Systems, Inc has had an increase in sales each of the last four years. They finished the year of 2014 with $ 11.2 million in sales reflecting top line growth of 29% from 2013.In each of the previous two years they had a 12% increase in sales. The company has had at least $ 700 million of net income in each of the past four years and has no debt.
REPR continues to increase revenues and create organic growth by using the cash from revenues to hire more staff, increase research efforts and expand marketing and sales.
The Freedom 60 has had success in Europe reflected in a huge sales increase of 47.8% first quarter 2015 up from same quarter 2014.
Undervalued Small Cap Medical Stocks
August 18, 2015 Show:
The August 18th show features a live interview with:
Immune Therapeutics Inc.
(Stock Symbol: IMUN),
CEO Noreen Griffin,
Dr Gloria Herndon
and Dr Richard Afonja
Visit The Corporate Site — ImmuneTherapeutics.com
See Corporate Investors Information and stock quote page: Click Here
Listen To Show Replay Part 1:
Hear Part 2 replay with IMUN interview:
Immune Therapeutics is a specialty pharmaceutical company undergoing a wide range of FDA testing of therapeutic protocols preparatory to the manufacture, commercialization, marketing, and distribution of their patented therapies.
Their novel concepts entail enhancing and refining both the activation and modulation of the body’s natural immune system.
LDN (Low Dose Naltrexone)
Low Dose Naltrexone used as an
immune modulator
Low Dose Naltrexone as it is known in the United States, or Lodonal as it is known internationally, has its origins in the FDA approved 50mg Naltrexone. Originally used to treat opiate dependences, the Immune Therapeutics patented treatments, which cover a wide range of indications (link to LDN patents), is currently used as an immune modulator. See Report — Click Here
Medical Stocks to Buy August 2015
The biotechnology company working to combat chronic, life-threatening diseases through the activation and modulation of the body’s immune system using our patented immunotherapy. Their Products and immunotherapy technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and autoimmune diseases. The company’s therapies have been demonstrated over time to be highly efficacious and virtually free of side negative effects.
Small Cap Medical Stock News
Partnership with GB Pharma and AHAR sign LOI with Fidson Healthcare Plc for the distribution of Lodonal in Nigeria Announced.
Immune Therapeutics Inc. in partnership with GB Pharma Holdings Inc and American Hospitals & Resort [AHAR], announces that they have signed a Letter of Intent with Nigerian public company, Fidson Healthcare Plc [NSE:FIDSON.LG] one of Nigeria’s leading pharmaceutical companies. — See News
Immune Therapeutics Inc, Announces the official publication announcement of the NAFDAC approved 90-Day Bridging Trial of Lodonal™ with HIV/AIDS Patients.
Immune Therapeutics Inc – Lodonal™ an Adjunct Immune Therapy for Treatment of Patients with HIV/AIDS
Immune Therapeutics Inc. CEO Issues Letter to Shareholders Highlighting Significant Progress — See News
Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. — See News
August 4, 2015 Show
The August 4th show features a live interview with:
Immune Therapeutics Inc.
(Stock Symbol: IMUN),
CEO Noreen Griffin,
Dr Jay Ellenby and
Dr Gloria Herndon
Visit The Corporate Site — ImmuneTherapeutics.com
See Corporate Investors Information and stock quote page: Click Here
Listen To Show Replay Part 1:
Listen To Show Replay Part 2 with Immune Therapeutics Interview:
Immune Therapeutics is a specialty pharmaceutical company undergoing a wide range of FDA testing of therapeutic protocols preparatory to the manufacture, commercialization, marketing, and distribution of their patented therapies.
Their novel concepts entail enhancing and refining both the activation and modulation of the body’s natural immune system.
LDN (Low Dose Naltrexone)
Low Dose Naltrexone used as an
immune modulator
Low Dose Naltrexone as it is known in the United States, or Lodonal as it is known internationally, has its origins in the FDA approved 50mg Naltrexone. Originally used to treat opiate dependences, the Immune Therapeutics patented treatments, which cover a wide range of indications (link to LDN patents), is currently used as an immune modulator. See Report — Click Here
Medical Stocks to Buy August 2015
The biotechnology company working to combat chronic, life-threatening diseases through the activation and modulation of the body’s immune system using our patented immunotherapy. Their Products and immunotherapy technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and autoimmune diseases. The company’s therapies have been demonstrated over time to be highly efficacious and virtually free of side negative effects.
Small Cap Medical Stock News
Partnership with GB Pharma and AHAR sign LOI with Fidson Healthcare Plc for the distribution of Lodonal in Nigeria Announced.
Immune Therapeutics Inc. in partnership with GB Pharma Holdings Inc and American Hospitals & Resort [AHAR], announces that they have signed a Letter of Intent with Nigerian public company, Fidson Healthcare Plc [NSE:FIDSON.LG] one of Nigeria’s leading pharmaceutical companies. — See News
Immune Therapeutics Inc, Announces the official publication announcement of the NAFDAC approved 90-Day Bridging Trial of Lodonal™ with HIV/AIDS Patients.
Immune Therapeutics Inc – Lodonal™ an Adjunct Immune Therapy for Treatment of Patients with HIV/AIDS
Immune Therapeutics Inc. CEO Issues Letter to Shareholders Highlighting Significant Progress — See News
Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. — See News
July 14, 2015 Show
Money Info
Investment News Show
The July 14, 2015 show featured a live interview with
RMS Medical Products, Inc.
(Stock Symbol: REPR)
President and Chairman of the Board
Andrew Sealfon
Listen to a replay of Part 1 of the show:
Listen to a replay of Part 2 of the show with Andrew Sealfon RMS Medical Products interview:
RMS Medical Products, Inc.
(Stock Symbol: REPR)
Visit the corporate website: http://www.rmsmedicalproducts.com
For REPR stock quotes, trading charts and their latest news releases visit this Yahoo Finance link: http://finance.yahoo.com/q?s=repr
Undervalued Small Cap Medical Stocks
REPR continues to increase revenues and create organic growth by using the cash from revenues to hire more staff, increase research efforts and expand marketing and sales.
STRONG GROWTH CONTINUES
REPR Annual Revenue and Profits Continue To Increase
New health insurance changes are forcing more and more home health care
A sector in which REPR excels.
Medical Growth Stock
RMS Stock has doubled this year already and can double again.
RMS designs, markets, manufactures portable easy to operate infusion devices, including needles and tubing. It is easy to handle by patients.
The Freedom 60 is being marketed in Europe as well as gaining a footing among home-care professionals in America. The RescueVac is used in ambulances and planes for emergency suction.
Sales for the FREEDOM 60® pump continue to produce spectacular grow.
RMS Medical Products specializes in developing and manufacturing portable medical devices, understanding that healthcare professionals need products that they can depend on in critical situations – that will work every time. For patients, these products are often profoundly uplifting to their quality of life.
With that in mind, REPR offers products for a wide variety of markets including hospitals, home healthcare, nursing homes and rescue services.
Primary products are:
FREEDOM60® Syringe Infusion System – Used for the subcutaneous administration of immune globulin offers safe, controlled pressure and ability to adjust automatically to the flow. The inherently safe pressures used to deliver drugs to patients minimize discomfort, swelling and other complications sometimes found with conventional electric infusion devices. There are additional applications such as the delivery of antibiotics and other drugs.
RES-Q-VAC® Emergency Suction – Fills a niche in emergency medicine, hospitals, and home care for immediate airway suction when and wherever needed. RES-Q-VAC® has patented filtration to minimize exposure of medical personnel to dangerous pathogens from patients infected with life threatening diseases such as tuberculosis and SARS. Because RES-Q-VAC® provides reliable suction without electric power, it is useful in disasters when the electricity fails.
RMS HIGH-Flo™ Subcutaneous Safety Needle Sets – RMS Successfully introduced this product to the US market during the 2012 fiscal year. Used with the Company’s FREEDOM60® pump or pumps from other manufacturers. The Company has received feedback from some SCIG patients experiencing less pain, less infusion time, and less discomfort when switching to High-Flo™.
See more product information at
http://www.rmsmedicalproducts.com/?node=products
June 30, 2015 Show
Skin Products Stocks
and
New Sunscreen Products Stocks on
Investment News Show
The show featured a live interview with
Terry Howlett,
President & CEO of
Skinvisible, Inc.
Stock Symbol: SKVI
Listen To Show Replay Part 1:
Listen To Show Replay Part 2 With Terry Howlett, Skinvisible CEO Interview:
The Show also featured a live interview with Tim Connolly of Texas Gulf Oil & Gas Inc. (See texasgulfoil.com site) and business funding and development specialists, Corporate Strategies, Inc. (See Site).
Listen To Show Replay Part 3 With Tim Connolly Oil Industry News Interview:
Corporate Strategies customizes a unique, immediate action plan to address each client’s specific needs. We assemble a team of seasoned professionals with extensive experience in your industry, who are experts in business development, finance, capital raising, operations, project management, due diligence and corporate restructuring services. The Corporate Strategies team is then ready to pursue the successful outcome as defined by our client.
Texas Gulf Oil and Gas, Inc. (TGOG) is an independent oil and gas company based in Houston,Texas with field offices in Luling,Texas.
- Our mission is to increase oil and gas production, using both conventional and proprietary enhanced production techniques, in previously proven production areas.
- Due to the opportunity presented by dramatically lower oil prices, TGOG has begun to acquire and develop a three year target of 5,000+ barrels of oil equivalent (boepd) in shallow well production (approx 6000’ depth and less) per day in long standing production areas throughout Texas
SKINVISIBLE PHARMACEUTICALS, INC.
See Skinvisible Corporate Site — Skinvisible.com Click Here
Get Skinvisible (SKVI) stock quote, trading chart and latest news from YAHOO finance — Click Here
Skinvisible, Inc., through its wholly owned subsidiary, Skinvisible Pharmaceuticals, Inc., is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products to treat acne, skin cancers, eczema, fungal infections, inflammation, warts and dermatitis along with sunscreens, anti-aging products, alcohol-free hand sanitizing lotions, pre-surgical preparations, and various other medical treatments using its patented technology Invisicare®. Skinvisible’s primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products.
Skin and Sunscreen Products Stocks
Skinvisible’s mission is to develop innovative technology and superior topical polymer delivery vehicles designed to significantly enhance product performance for established brand manufacturers and marketers of Rx and OTC dermatological, medical, cosmetic and skincare products.
It is Skinvisible’s intention to direct its ongoing energies and resources towards the following objectives:
- To capitalize on licensing opportunities for its Invisicare technology and formulated products to established pharmaceutical, medical, cosmetic, skincare and consumer goods manufacturers.
- To develop new polymer delivery vehicles designed to create or enhance formulated products for existing and new customers for a variety of applications.
- To enter into strategic relationships and attract alliances to expand research, development and collaborative product investigations for its patented polymer delivery vehicles and formulations.
- To increase on-going revenues and profitability from current licensees.
- To maximize shareholder value.
Terry Howlett — President & Chief Executive Officer
Mr. Howlett founded Skinvisible, Inc. in 1998. With over 30 years of entrepreneurial, business management and market initialization experience, he drives and directs the Company’s development and technology vision. He is adept at guiding emerging and publicly traded start-up companies through the stages of capital formation, strategic planning and business growth; specializing in venture capital financing. Mr. Howlett’s diversified background includes senior management, marketing, and sales positions with both established and start-up companies.
Sunscreen Products Stock NEWS
SKINVISIBLE’S KINTARI REVOLUTIONIZES THE SUNSCREEN MARKET – Skinbrella® Officially Launched — SEE NEWS
Skinvisible Inc., (OTCQB: SKVI) through its wholly-owned subsidiary Kintari International Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official launch of Skinbrella®, a patented sunscreen like no other. Skinbrella meets or exceeds all FDA requirements for a broad-spectrum, 80 minute water-resistant sunscreen.
“With millions of new skin cancer diagnosis each year, sun protection should be a daily lifestyle choice for everyone,” said Mr. Terry Howlett, President of Kintari. “The challenge of course is many sunscreens breakdown when exposed to sunlight or esthetically they are not pleasing. Kintari provides a solution to everyone’s daily sunscreen needs with Skinbrella. Today we are thrilled to announce that Skinbrella; a truly remarkable sunscreen with the patents to prove it, is available on Kintari.com and through our independent distributors and their websites.”
Skinbrella is a broad spectrum, SPF 30 sunscreen made with the Company’s patented topical delivery technology Invisicare®. It provides 80 minutes of water resistance; the highest designation allowed by the FDA. Skinbrella glides on smoothly without any sticky after feel, while still allowing the skin to breath naturally. It meets the requirements to be labeled “broad spectrum”, signifying it provides both UVA and UVB protection.
SKINVISIBLE SUBSIDIARY KINTARI HAS SUCCESSFUL LAUNCH – Kintari Officially In Business — SEE NEWS
Skinvisible Inc., (OTCQB: SKVI) through its wholly owned subsidiary Kintari International Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the successful official launch of its network marketing company.
“We are very pleased to announce that our January 15th official launch of Kintari in the USA was very exciting for us and the new distributors that attended from across the US,” said Mr. Terry Howlett, President of Kintari.
The Kintari product portfolio consists of “Youth Renewed” (YR) anti-aging products to help fight the signs of aging. The Kintari YR product line includes a rejuvenating day cream and a renewing night cream. These products have been developed using proven anti-aging ingredients with scientific evidence of their effectiveness at reducing the look of fine lines and wrinkles resulting in youthful looking skin. These potent ingredients are powered by our patented Invisicare® skin delivery technology, providing consumers with unique, effective skincare benefits which cannot be duplicated and our Kintari distributors with products that no other company can offer. Kintari products are truly one of a kind.
SKINVISIBLE’S SUBSIDIARY KINTARI ANNOUNCES NETWORK MARKETING EXPERT DEAN ALDRIDGE AS MASTER DISTRIBUTOR — SEE NEWS
Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) – through its wholly owned subsidiary Kintari International Inc., makers of patented “Youth Renewed” skin care products – is pleased to announce the selection of R. Dean Aldridge in the key role of Master Distributor. Dean will spearhead distributor expansion and development globally.
“We are very pleased to have Dean Aldridge, a world class marketer and sales leader, as our Master Distributor for Kintari,” said Terry Howlett, President of Kintari. “The Master Distributor plays a crucial role in the upward trajectory of the number of distributors that join Kintari and the sales they produce. Dean has exactly the skills and experience to make Kintari a huge success.” He added, “Dean has proven his skills over the past fifteen years in the network marketing industry. He is a multiple award winner and has climbed to the highest level of every company he has been associated with. Dean is often referred to as one of the top recruiters as well as one of the best relationship builders our industry has seen. His expertise has taken him to the top echelons of financial rewards and is touted as one of network marketing’s most distinguished international leaders.”
Investment News Show
Money Info Show
Replay Archives
Return to Main
Investing News Show Page
Hear Replays of
June 2015 to April 2015 Shows
Click Here
Hear Replays of
March 2015 to October 2014 Shows
Click Here
Hear Replays of
September 2014 to July 2014 Shows
Click Here
Hear Replays of
July and June 2014 Shows
Click Here
Hear Replays of
May, April and March 2014 Shows
Click Here
Hear Replays of
January and February 2014 Shows
Click Here
Hear Replays of
December and November 2013 Shows
Click Here
Hear Replays of October 2013 Shows
Hear Replays of September 2013 Shows:
Click Here
Hear Replays of August 2013 Shows
Click Here
June 2013 and July 2013
Money Info Show Replays
Click Here
April 2013 and May 2013
Money Info Show Replays
Click Here
March 2013 and February 2013
Money Info Show Replays
Click Here
January 2013
Money Info Show Recaps
Click Here
November 2012
Money Info Show Replays
Get recaps of November Shows
October 2012
Money Info Show Replays
Get recaps of October Shows
September 2012
Money Info Show Replays
See past show recaps
The Princeton Research Money Info Show features
where to invest now, stock market, business,
economy and financial investment news.
Stock Options Trading Alerts Update:
In order to make more investors aware of the exceptional gains we are producing with our Options Trading Alerts Service we are offering (for a very limited time) free sample trade alerts and sample issues of the Market Strategies Newsletter.
See http://www.princetonresearch.com/options-trading.htm to get in today.
